Vascepa Pricing and Discounts: What You Need to Know
Pricing for Vascepa, a prescription medication used to treat patients with high triglycerides, varies depending on factors like insurance coverage, location, and dosage strength. However, since Vascepa's patent has expired, several generic versions have entered the market, which may influence pricing.
Vascepa's Patent Expiration
The original Vascepa patent held by Amarin Pharmaceutical Inc. (now known as Athera Biotechnologies) expired on May 17, 2025, [1]. According to DrugPatentWatch.com, the patent expiration marked the beginning of a more competitive market, allowing other manufacturers to develop and sell generic versions of the medication [2].
Generic Pricing Options
As a result of increased competition, prices for generic Vascepa (icosapent ethyl) have declined. In the United States, according to GoodRx, a popular prescription price comparison website, the average cost of generic Vascepa without insurance can range from $30 to $50 per 1000mg capsule [3]. Prices may be lower with insurance, but copays and deductibles will apply.
Manufacturer Discounts and Programs
Athera Biotechnologies, the manufacturer of branded Vascepa, has made efforts to provide financial assistance to patients. Their Vascepa Savings Card program, for example, can help eligible patients with a maximum savings of $300 per month on branded Vascepa prescriptions [4].
Comparison to Other Treatments
Other medications for treating high triglycerides, such as Lovaza and Tricor, are available but may differ in pricing and effectiveness.
Patient Assistance Options
For eligible patients, pharmaceutical companies, patient advocacy groups, and government programs like Medicaid and Medicare can offer assistance programs to help cover medication costs, including Vascepa.
Refer to the sources below for additional information on Vascepa pricing, patient assistance, and generic versions:
[1] U.S. Patent and Trademark Office (UTime)
[2] DrugPatentWatch.com (DrugPatentWatch)
[3] GoodRx (GoodRx)
[4] Athera Biotechnologies (AtheraBiotechnologies)